2008
DOI: 10.2353/ajpath.2008.070988
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Characterization of Human Breast Tumor Vascular Cells

Abstract: A detailed understanding of the assortment of genes that are expressed in breast tumor vessels is needed to facilitate the development of novel, molecularly targeted anti-angiogenic agents for breast cancer therapies. Rapid immunohistochemistry using factor VIII-related antibodies was performed on sections of frozen human luminal-A breast tumors (n ‫؍‬ 5) and normal breast (n ‫؍‬ 5), followed by laser capture microdissection of vascular cells. RNA was extracted and amplified, and fluorescently labeled cDNA was… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
100
0
4

Year Published

2009
2009
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 111 publications
(108 citation statements)
references
References 31 publications
4
100
0
4
Order By: Relevance
“…We have identified novel tumor-specific vasculature markers which appear promising for cancer serum diagnostics, molecular imaging and/or therapeutic targeting applications and warrant further clinical development. 4 Raphael sandaltzopoulos, 2 Andrew K. Godwin, 4 Nathalie scholler 1 and George Coukos 1, therapeutically to achieve destruction of established tumors or to prevent solid tumor growth by disrupting the tumor vasculature. Recent encouraging results with VEGF blockade have demonstrated the feasibility and efficacy of targeting tumor angiogenesis, [10][11][12][13] while vascular disrupting agents have produced dramatic results in preclinical models.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…We have identified novel tumor-specific vasculature markers which appear promising for cancer serum diagnostics, molecular imaging and/or therapeutic targeting applications and warrant further clinical development. 4 Raphael sandaltzopoulos, 2 Andrew K. Godwin, 4 Nathalie scholler 1 and George Coukos 1, therapeutically to achieve destruction of established tumors or to prevent solid tumor growth by disrupting the tumor vasculature. Recent encouraging results with VEGF blockade have demonstrated the feasibility and efficacy of targeting tumor angiogenesis, [10][11][12][13] while vascular disrupting agents have produced dramatic results in preclinical models.…”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3][4][5][6] Tumor vessels are enmeshed in a complex tissue, which includes tumor cells, stromal cells and leukocytes. Interactions with these cells and their products (growth factors, cytokines etc.)…”
Section: Introductionmentioning
confidence: 99%
“…Although transcriptional profiling has matured as a diagnostic and prognostic research tool in pathology 11 and has been widely used to characterize malignancies as diverse as renal cell carcinoma, 12 prostate cancer, 13 metastatic bone cancer 14 and breast cancer, 15 proteinbased biomarkers may have potentially greater diagnostic power than genetic or transcriptional profiles because they may reflect disease-related alterations to tissue that are invisible to gene-based analyses. 16 Protein expression and activity are subject to additional layers of metabolic regulation over and above the regulation of gene expression.…”
mentioning
confidence: 99%
“…In this regard, few papers have compared the expression profile of TEC versus their healthy counterpart defining several differentially expressed gene families (Bhati et al, 2008;Ghilardi et al, 2008). Nonetheless, although the expression and role of TRP channels in the vascular endothelium is well recognized and is subject of a number of recent reviews (Nilius and Droogmans, 2001;Yao and Garland, 2005), only recently TRPs have been recognized as major players in tumor vascularization (Fiorio Pla et al, 2012b;Fiorio Pla et al, 2012;Fiorio Pla and Gkika, 2013).…”
Section: Trp Expression In Cancermentioning
confidence: 99%